Last update 09 Feb 2026

Autologous tumor-reactive T cells (GK02)

Overview

Basic Info

Drug Type
TIL therapy
Synonyms
GK-02
Target-
Action-
Mechanism
T lymphocyte replacements
Therapeutic Areas
Other Diseases
Active Indication
Malignant ascites
Inactive Indication-
Originator Organization
Beijing Geek Gene Technology Co., LtdBeijing Geek Gene Technology Co., Ltd
Active Organization
Beijing Geek Gene Technology Co., LtdBeijing Geek Gene Technology Co., Ltd
Inactive Organization-
License Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with Autologous tumor-reactive T cells (GK02)
NCT07378436
/ RecruitingEarly Phase 1
A Single-Arm, Single-Center, Open-Label Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of Autologous Tumor-Reactive T Cells(GK02) Derived From Malignant Ascites Caused by Advanced Solid Tumors
100 Clinical Results associated with Autologous tumor-reactive T cells (GK02)
Login to view more data
100 Translational Medicine associated with Autologous tumor-reactive T cells (GK02)
Login to view more data
100 Patents (Medical) associated with Autologous tumor-reactive T cells (GK02)
Login to view more data
100 Deals associated with Autologous tumor-reactive T cells (GK02)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Malignant ascitesPhase 1
China
Beijing Geek Gene Technology Co., LtdBeijing Geek Gene Technology Co., Ltd
16 Sep 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free